Reps. Westerman, Gallagher, Burchett, Braun Introduce Bicameral Prescription Drug Legislation
January 10, 2020
January 10, 2020
WASHINGTON, Jan. 10 -- Rep. Bruce Westerman, R-Arkansas, issued the following news release:
U.S. Reps. Bruce Westerman (R-Ark.), Mike Gallagher (R-Wis.) and Tim Burchett (R-Tenn.) and U.S. Sen .Mike Braun (R-Ind.) introduced the bicameral Conditional Approval Act, which would establish a pathway in the United States Food and Drug Administration (FDA) to increase access and lower costs of prescription drugs.
"Americans face the highest prescription drug costs of any . . .
U.S. Reps. Bruce Westerman (R-Ark.), Mike Gallagher (R-Wis.) and Tim Burchett (R-Tenn.) and U.S. Sen .Mike Braun (R-Ind.) introduced the bicameral Conditional Approval Act, which would establish a pathway in the United States Food and Drug Administration (FDA) to increase access and lower costs of prescription drugs.
"Americans face the highest prescription drug costs of any . . .